The Frontier Awards are the most prestigious ones and are regarded as the "Oscars" of the Duty Free industry. The award was given to the ADDF during the 19th Tax Free World Exhibition, held in Cannes ...

On Thursday, April 7, the Centers for Medicare and Medicaid (CMS) formalized its plan to cover the anti-amyloid drug Aduhelm only for patients enrolled in clinical trials. However, in response to ...

NEW YORK, March 17, 2026 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) today announced the launch of the third phase of its Diagnostics Accelerator (DxA), backed by an additional ...

Add Yahoo as a preferred source to see more of our stories on Google. Jo Carole Lauder and Jane Lauder at the Alzheimer's Drug Discovery Foundation Fifth Annual Hope on the Horizon Event at The Beach ...

The Clinical Trials on Alzheimer's Disease (CTAD) conference and the Alzheimer's Drug Discovery Foundation (ADDF) today ...

NEW YORK, Dec. 16, 2025 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) today announced two new members to its Board of Governors: Gavin Cook, Executive Director of Global Alzheimer's ...

The Alzheimer's Drug Discovery Foundation (ADDF) and Harrington Discovery Institute at University Hospitals in Cleveland have granted an ADDF-Harrington Scholar Award to Christiane Wrann, PhD, DVM, ...

Online sales of the Abu Dhabi Duty Free “Big Ticket” have virtually doubled since the launch of their new website recently. The new site has been designed in a modern and contemporary way and caters ...

San Francisco, CA (November 30, 2022) – The phase 3 trial results for lecanemab and gantenerumab presented at the Clinical Trials on Alzheimer’s Disease (CTAD) conference demonstrate why optimal ...

Findings point to continued momentum toward combination therapies that target the full pathobiology of the disease NEW YORK, May 14, 2026 /PRNewswire/ -- Today, Biogen announced topline results from ...

Please provide your email address to receive an email when new articles are posted on . The Alzheimer’s Drug Discovery Foundation has invested $5 million in Coya Therapeutics to help accelerate ...

NEW YORK, NY (1/5/2021) - Subtle changes in speech and language can be an early warning sign of Alzheimer's -- sometimes appearing long before other more serious symptoms. The challenge is recognizing ...